Autoimmune-like Drug-induced Liver Injury Caused by Atorvastatin and Demonstration of the Safety Profile of Pravastatin: A Case Report and Literature Review
Open Access
- 17 March 2020
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 12 (3) , e7299
Abstract
Statin-induced liver injury is a well-recognized but rare phenomenon with hepatocellular, cholestatic, and mixed phenotypes. Most studies do not recommend regular monitoring of liver function tests (LFTs) after starting statins unless clinically indicated. We report a case of autoimmune-like atorvastatin-induced liver injury (aminotransferases > 5 times the upper limit of normal) that was detected on routine follow-up after three months in an asymptomatic patient. In addition to elevation in transaminases, the patient had weakly positive ANAs. Anti-smooth muscle antibody (ASMA) was positive in titers of 1:680. Screening for viral hepatitis A-E was negative. Other diagnostic investigations showed complete blood examination, including eosinophils, renal function tests, electrolytes, total protein, albumin, prothrombin time, activated partial thromboplastin time (aPTT), international normalized ratio (INR), serum ferritin, and iron saturation to be in the normal range. Ultrasound and computed tomography (CT) abdomen showed normal liver, gall bladder, biliary tree, and pancreas. The patient was managed as a case of autoimmune-like drug-induced liver injury (DILI) caused by atorvastatin and the medication was discontinued. LFTs returned to completely normal 30 days after the discontinuation of atorvastatin. Furthermore, switching to pravastatin for dyslipidemia management four months after stopping atorvastatin did not lead to hepatotoxicity, illustrating the safety profile of pravastatin in patients who are unable to tolerate atorvastatin.Keywords
This publication has 12 references indexed in Scilit:
- “Autoimmune(-Like)” Drug and Herb Induced Liver Injury: New Insights into Molecular PathogenesisInternational Journal of Molecular Sciences, 2017
- Statin‐related aminotransferase elevation according to baseline aminotransferases level in real practice in KoreaJournal of Clinical Pharmacy and Therapeutics, 2016
- Statins and its hepatic effects: Newer data, implications, and changing recommendationsJournal of Pharmacy and Bioallied Sciences, 2016
- ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver InjuryAmerican Journal of Gastroenterology, 2014
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsCirculation, 2014
- Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury networkHepatology, 2014
- Atorvastatin-induced acute elevation of hepatic enzymes and the absence of cross-toxicity of pravastatinInt. Journal of Clinical Pharmacology and Therapeutics, 2010
- Statins and hepatotoxicityHepatology, 2005
- Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic DrugsSeminars in Liver Disease, 2002
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993